The rise of antibiotic resistance in India has become a double-edged sword, affecting both public health and the financial stability of families. According to a recent study by the Indian Council of Medical Research (ICMR) published in BMJ Open, treating antibiotic-resistant infections costs significantly more than treating drug-susceptible infections. This financial burden is forcing many families into debt and financial crises.

The Cost of Antibiotic Resistance

The study highlights the sharp increase in treatment expenses when infections are caused by drug-resistant bacteria. Key findings include:

• Treating resistant infections in private hospitals costs 10.6% more than drug-susceptible infections.
• In private hospitals, managing resistant infections costs an average of $3,382, compared to $215 in charity trust-run hospitals.
• Many patients with resistant infections require expensive drugs and ICU stays, further escalating costs.

Financial Toxicity Faced by Families

The financial burden on families dealing with resistant infections is alarming:

• 46.5% of families borrowed money to cover treatment costs.
• 33.1% had to withdraw savings, reaching “grade 2 financial toxicity.”
• 11.4% of families with resistant infections had to sell or mortgage assets, indicating “grade 4 financial toxicity.”
• Some families even cut down on food consumption to manage medical expenses.

Why Antibiotic Resistance Is Rising

The widespread misuse of antibiotics in both healthcare and agriculture is a primary driver of antimicrobial resistance (AMR). According to an intensivist at H N Reliance Hospital:

• Infections caused by resistant bacteria are now being acquired in communities, not just in hospitals.
• Overuse of antibiotics in the poultry industry contributes significantly to this crisis.

Role of Hospitals and Stewardship Programs

Efforts to combat antibiotic resistance include the adoption of antibiotic stewardship programs in many hospitals, thanks to government initiatives. These programs aim to:

• Educate healthcare providers on the proper use of antibiotics.
• Reduce unnecessary prescriptions and ensure appropriate antibiotic use.

However, a senior ICMR scientist and co-author of the study emphasized the challenge of sustaining these programs in the long term.

The Way Forward

To address the antibiotic resistance crisis, coordinated efforts are needed:

1. Strengthen Stewardship Programs: Hospitals must adopt and sustain antibiotic stewardship initiatives to prevent misuse.
2. Public Awareness Campaigns: Educate communities on the dangers of overusing antibiotics.
3. Regulate Antibiotic Use in Agriculture: Enforce stricter guidelines to limit antibiotic use in poultry and livestock.
4. Affordable Treatment Options: Improve access to cost-effective treatment options, especially in rural areas and private healthcare settings.
5. Government Support: Policies to support families facing financial toxicity from resistant infections should be prioritized.

Conclusion

The fight against superbugs is not just a healthcare issue; it’s a financial crisis for many Indian families. Rising antimicrobial resistance (AMR) is driving up treatment costs, pushing families into debt, and threatening public health.

Healthcare providers must work together to promote responsible antibiotic use, adopt stewardship programs, and advocate for policies that make treatment affordable. By addressing the root causes of antibiotic resistance, we can prevent the spread of superbugs and alleviate the financial burden on patients and their families.

To register for our next masterclass please click here https://linktr.ee/docpreneur